OPEN CFDA 95.005 ↗ Competitive Cooperative Agreement Competitive ~100h typical effort

FY 2026 DRUG COURT TRAINING AND TECHNICAL ASSISTANCE COMPETITIVE COOPERATIVE AGREEMENT SOLICITATION

🏛 Office of National Drug Control Policy

✓ Free, no account · Source: Grants.gov · Last verified Jul 16, 2026

⏰ Deadline
Aug 27, 2026 in 41 days
💰 Award amount
$6M – $6M
📊 Total program funding
$6M
🎯 Expected awards
1 recipient
📍 Scope
National

Can you apply?

This grant is for organizations that provide training and technical assistance on evidence-based addiction treatment in drug courts.

Eligible applicants typically include nonprofit organizations, universities, research institutions, and public agencies with expertise in addiction treatment and criminal justice. Applicants must demonstrate capacity to employ expert practitioners and licensed behavioral health professionals.

The grant supports work at state, local, and tribal levels nationwide, including rural areas. Funding supports training materials, in-person and online training, jurisdiction-specific technical assistance, and independent outcome evaluation aligned with Trump Administration drug policy priorities.

Eligible applicants
Check your eligibility — what type of organization are you?

Not the right fit? Find grants for your organization in 5 questions →

Program description

ONDCP’s Drug Court Training and Technical Assistance Cooperative Agreement supports training and technical assistance (TTA) to ensure access to evidence-based addiction treatment through drug courts, including when substance use disorder co-occurs with other mental healthconditions. ONDCP seeks to reduce drug use and its consequences through evidence-based treatment that leads to long-term recovery, and this cooperative agreement will support the President’s priorities by applying this to the criminal justice system. The purpose of this cooperative agreement is to: (1) educate, train, and produce materials to improve the implementation of evidence-based treatment to individuals with addiction, including when substance use disorder co-occurs with other mental health conditions; (2)decrease criminal justice costs and recidivism rates; and (3) improve access to evidence-based addiction treatment that includes medications for opioid use disorder through drug courts. The cooperative agreement recipient shall:• Use expert practitioners in the science of addiction and evidence-based addiction treatment, as well as integration of treatment into the criminal justice system.• Use licensed behavioral health practitioners.• Provide in-person training, online training, and jurisdiction-specific technical assistanceto a wide range of geographically distributed areas—including rural locations—at thestate, local, and tribal levels.• Ensure close alignment of all TTA materials with the Trump Administration’s policy priorities, including the 2026 National Drug Control Strategy; an evidence-based approach to treating addiction–to include FDA-approved medications for opioid use disorder–contingency management, and other evidence-based behavioral health modalities for other substance use disorders; naloxone distribution and naloxone training.• Designate and fund a research or academic organization to conduct an independent assessment of the effectiveness and impact of training and technical assistance conducted under this cooperative agreement. The independent study should involve data collectionfrom state, local, and tribal jurisdictions engaged in cooperative agreement recipient programming.

Who can apply

Eligible applicants

How to apply

Application links

Key dates & requirements

  • 📄 Narrative page limit: 30 pages
  • Project period: 24 months
  • 🧾 Budget narrative required. Free budget template →

Required documents

  • SF-424 (Application for Federal Assistance)
  • Project Narrative
  • Budget and Budget Narrative
  • Organizational capacity documentation (staffing, qualifications)
  • Evaluation plan
  • Letters of support from state, local, or tribal partners

Program contact

Funding track record

No recent recipient data available for CFDA 95.005 in our database.

This can happen for newer programs, programs that use non-standard award types (loans, direct payments, fellowships), or those funded through sub-agencies under different codes.

Search this CFDA directly on USAspending.gov →

Funding history

Annual funding for this program — Federal obligations (CFDA 95.005). How funding has trended year over year.

2024 $6,350,000
2026 est. $3,000,000

FAQ

Who can apply for this grant?

Nonprofit organizations, universities, research institutions, and public agencies with expertise in addiction treatment and criminal justice. You must have licensed behavioral health practitioners on staff or under contract.

What activities does this funding support?

Training development, in-person and online training delivery, jurisdiction-specific technical assistance, and independent program evaluation. Work should serve state, local, and tribal drug courts including rural areas.

What is the funding amount?

The award is fixed at $6,000,000 for the cooperative agreement recipient. No cost-sharing is required.

What outcomes matter most to reviewers?

Demonstrated capacity to train drug court teams, reduce recidivism and costs, and expand access to FDA-approved medications for opioid use disorder. Alignment with Trump Administration drug policy priorities is expected.

When is the deadline?

The deadline is August 27, 2026. This is a fixed deadline, not rolling.

💡 Tips for applicants

  • Build your application team with recognized experts in addiction science and evidence-based treatment. Include licensed behavioral health practitioners with criminal justice experience.
  • Emphasize your capacity to reach geographically dispersed areas including rural jurisdictions. Show past success training at state, local, and tribal levels.
  • Propose a robust independent evaluation plan. Include data collection methods from multiple jurisdictions and clear metrics on recidivism reduction and medication access.
  • Align all training content and messaging with Trump Administration priorities: FDA-approved opioid medications, contingency management, naloxone distribution, and integration with criminal justice.
  • Demonstrate financial stability and organizational capacity to manage a $6 million award. Include detail on staffing, equipment, and infrastructure needs for multi-year operations.

⚠️ Common mistakes

Submitting without evidence of clinical expertise in addiction treatment or partnerships with licensed practitioners. Proposing training without clear alignment to Trump Administration drug policy priorities including medication-assisted treatment and naloxone access. Failing to include a detailed, independent evaluation plan with specific data collection from jurisdictions.

Similar grants

41 days left Aug 27, 2026
Apply →